Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 817,258 | 639,113 | 606,417 | 690,846 | 661,824 |
| Cost of Goods | 169,631 | 147,591 | 149,048 | 148,739 | 127,776 |
| Gross Profit | 647,626 | 491,522 | 457,463 | 542,200 | 534,048 |
| Operating Expenses | 1,053,839 | 387,578 | 330,130 | 389,804 | 339,080 |
| Operating Income | -405,476 | 104,535 | 127,380 | 153,137 | 195,648 |
| Interest Expense | 17,657 | 22,356 | 24,576 | 28,872 | 31,296 |
| Other Income | -105 | 0 | 0 | 8,230 | 0 |
| Pre-tax Income | -423,238 | 82,179 | 102,805 | 132,495 | 164,352 |
| Income Tax | -118,973 | 16,560 | 20,730 | 3,887 | 23,808 |
| Net Income Continuous | -304,265 | 65,619 | 82,075 | 128,608 | 140,544 |
| Minority Interests | N/A | -207 | N/A | N/A | N/A |
| Net Income | $-304,159 | $65,826 | $82,075 | $129,175 | $140,544 |
| EPS Basic Total Ops | -0.88 | 0.19 | 0.24 | 0.38 | 0.41 |
| EPS Basic Continuous Ops | -0.88 | 0.19 | 0.24 | 0.38 | 0.41 |
| EPS Diluted Total Ops | -0.87 | 0.19 | 0.24 | 0.37 | 0.41 |
| EPS Diluted Continuous Ops | -0.87 | 0.19 | 0.24 | 0.37 | 0.41 |
| EPS Diluted Before Non-Recurring Items | 0.64 | 0.24 | 0.26 | 0.37 | 0.40 |
| EBITDA(a) | $387,169 | $205,645 | $215,271 | $237,364 | $289,094 |